Astrana Health (ASTH) Net Margin (2010 - 2026)

Astrana Health has disclosed Net Margin across 17 years of filings, most recently posting 1.36% for Q1 2026.

• Net Margin for Q1 2026 came in at 1.36%, up 36.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.76% (down 80.0% YoY), and the FY2025 annual result was 0.62%, down 162.0% from the prior year.
• Net Margin came in at 1.36% for Q1 2026 at Astrana Health, up from 0.24% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 8.03% in Q3 2023 to a low of 3.55% in Q4 2023.
• The 5-year median for Net Margin is 3.7% (2023), against an average of 2.59%.
• Peak annual rise in Net Margin reached 984 bps in 2022, while the deepest fall reached 2602 bps in 2022.
• Astrana Health's Net Margin stood at 0.3% in 2022, then tumbled by 1083 bps to 3.55% in 2023, then jumped by 49 bps to 1.81% in 2024, then soared by 113 bps to 0.24% in 2025, then surged by 468 bps to 1.36% in 2026.
• The last three Net Margin figures came in at 1.36% (Q1 2026), 0.24% (Q4 2025), and 0.11% (Q3 2025), per Business Quant data.